Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-07-05
1997-08-26
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544139, 546199, 5483047, 5483061, 5483064, A61K 31415
Patent
active
056611692
ABSTRACT:
The present invention relates to 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, of formula: ##STR1## and to the possible salts thereof, to a process for their preparation and to the pharmaceutical compositions containing them.
These compounds have an affinity for the vasopressin and/or oxytocin receptors.
REFERENCES:
patent: 4377695 (1983-03-01), Lautenschlager et al.
patent: 5200422 (1993-04-01), Olesen et al.
patent: 5258510 (1993-11-01), Ogawa et al.
Di Malta Alain
Garcia Georges
Mettefeu Daniel
Roux Richard
Serradeil-Legal Claudine
Ramsuer Robert W.
Sanofi
LandOfFree
1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988829